Literature DB >> 32472281

CPAP is associated with decreased risk of AF recurrence in patients with OSA, especially those younger and slimmer: a meta-analysis.

Yunxiao Yang1, Yu Ning1, Wanwan Wen1, Yifan Jia1, Xiaoyuan Chen2, Mengling Huang1, Jaskanwal Deep Sara3, Yanwen Qin4, Fang Fang4, Huina Zhang4, Yunhui Du4, Linyi Li4, Xiaolu Jiao4, Yunyun Yang4, Xingyu Han4,5, Ming Zhang6, Yongxiang Wei7.   

Abstract

PURPOSE: Obstructive sleep apnea (OSA) is associated with the management of atrial fibrillation (AF). This manuscript aims to discuss the effects of continuous positive airway pressure (CPAP) in patients with rhythm control strategies and patients with different ages, weights and length of follow-up.
METHODS: We searched Embase, PubMed, Cochrane, Web of Science and Ovid for relevant studies (from inception to 7 July 2019; English). The primary outcome was documented AF recurrence in CPAP users and nonusers. We assessed pooled data by use of a random-effects model.
RESULTS: Nine prospective cohort studies with a total of 2134 participants met the inclusion criteria. Results showed that complementary CPAP therapy reduced AF recurrence (RR = 0.63; 95% CI, 0.56-0.72). In subgroup analyses, the benefits of CPAP were stronger in patients younger than 60 years old (< 60 years old: RR, 0.59; 95% CI, 0.50-0.68 vs. ≥ 60 years old: RR, 0.73; 95% CI, 0.59-0.91), with a body mass index (BMI) of less than 30 (< 30: RR, 0.53; 95% CI, 0.37-0.77 vs. ≥ 30: RR, 0.65; 95% CI, 0.55-0.77) or with less follow-up time (≤ 1 year: RR, 0.57; 95% CI, 0.42-0.79 vs. > 1 year: RR, 0.64; 95% CI, 0.53-0.78).
CONCLUSIONS: Complementary CPAP therapy reduces the risk of AF recurrence in OSA patients with rhythm control strategies. In addition to weight control and early AF intervention, CPAP compliance should be recommended along with periodic adjustments as necessary.

Entities:  

Keywords:  Atrial fibrillation; Continuous positive airway pressure; Obstructive sleep apnea; Recurrence

Year:  2020        PMID: 32472281     DOI: 10.1007/s10840-020-00738-6

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  3 in total

1.  Should we incorporate obstructive sleep apnea in CHA2DS2-VASc score?

Authors:  Christos Goudis; Stylianos Daios; Panagiotis Korantzopoulos; Tong Liu
Journal:  Sleep Breath       Date:  2021-02-01       Impact factor: 2.816

2.  Screening for Obstructive Sleep Apnea in an Atrial Fibrillation Population: What's the Best Test?

Authors:  Samantha Y Starkey; Daniel R Jonasson; Stephanie Alexis; Susan Su; Ravinder Johal; Paul Sweeney; Penelope M A Brasher; John Fleetham; Najib Ayas; Teddi Orenstein; Iqbal H Ahmed
Journal:  CJC Open       Date:  2020-12-03

3.  Association between obstructive sleep apnea (OSA) and atrial fibrillation (AF): A dose-response meta-analysis.

Authors:  Dong Zhang; Yibo Ma; Jian Xu; Fu Yi
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.